Buying Appreciation

As I’ve gotten older, I’ve grown much better at making purchases that I don’t regret. This includes clothing, tech, furniture, appliances, and more.

When I was younger, I often made poor choices in this area.

Here’s the key difference.

When I was younger, I would basically ask these types of questions when considering purchase options:

  • What’s good enough?
  • What can I afford?
  • What’s the best value?
  • Where can I get the best deal?
  • How can I get this for less?
  • How can I save money on this?
  • What will satisfy me?
  • What will get the job done?
  • What’s the best bang per buck?

These questions led me to focus mainly on value. I often wanted to feel like I was getting a good deal. To me a good deal meant a reasonable level of quality at a good or great price.

And that’s basically what I got. I’d buy items that were adequate for my needs, and I’d often find ways to get them at good or great prices. The price alone could be a strong motivator.

Today I think differently about making purchases. Now I tend to ask these types of questions when considering a purchase:

  • What do I really want?
  • What excites me?
  • Which option would I appreciate most?
  • What would feel too good to have? Is it really too good?
  • What would I get if I could afford anything?
  • What do I want the simulator to simulate?
  • Which option feels abundant?
  • Which option feels like I’d need to justify or explain it?
  • Which option feels edgy or exciting?
  • Where’s the lust? What am I lusting after?

I still love a good deal, but I’ve found it best not to make that my main concern. These days I’d rather buy a great option at a decent price than buy a good option at a great price.

What I’ve discovered is that appreciation is worth paying for. It’s worth paying more for better quality. I define better quality as items that feel a bit indulgent to me. Sometimes these items feel almost sinful.

When I made a so-so purchase, I normally don’t appreciate the item as much after I’ve bought it. Owning it isn’t as exciting as getting it. There’s a bit of a letdown after the purchase is made.

But when I make a really aligned purchase, I typically like and appreciate the item at least as much after I have it and sometimes even more. I’ll often comment, “I like this even more than I thought I would.”

This doesn’t necessarily mean I have to spend extra, although sometimes that can be a factor. It’s more about focusing on my feelings and seeing where they lead. It helps to slide away from being too objective and to consider the subjective lens.

The key is to pay more respect to the emotional reality of a purchase. I now give more weight to how much I’m likely to appreciate and value an item for the time it will be with me. In the past I felt like I always had to have extra justification for that, like any excess emotion had to be balanced with extra logic, especially if I had to pay more for some increased emotional satisfaction. Now I realize that spending for gratification is actually a wise choice in general and that I don’t need to go overboard in trying to justify that.

Consequently, I feel that my life is becoming richer in possessions that I really like. I still fumble sometimes, but I can see that I’m doing a better job of aligning my physical environment with a mindset of abundance.

Interestingly I also find that this attitude helps to drive my income higher because it carries over to the income side. Just as I think about spending to create emotional value, I also think about how different approaches to income generation will create different levels of emotional value. This helps me invest in income streams that enrich my life emotionally. If I feel good about a stream emotionally, it’s easier to keep investing in it, and it also removes some friction.

A common source of friction is when you don’t really like what you’d have to do to increase your income. If you can reduce that friction, it’s easier to grow your income and while enjoying the process.

What kinds of questions do you ask when considering a purchase decision? See if you can articulate what’s going through your mind. Turn that inner mindset into a short list of questions. Then look at those questions, and consider how they may be affecting you. Can you see how your buying mindset links up with your long-term appreciation?

Also notice which possessions you appreciate the most. What mindset did you use for them? What questions did you ask?

When you can identify the mindset (and the questions) that generate the most appreciation and the least regret, you can apply that mindset more deliberately. Then you can shorten it to a quick rule of thumb to use again and again.

Note that this is mostly a subjective mindset, but it carries over to the objective side. Thinking about appreciation is a shortcut that helps me pay a more attention to the full ownership experience, including potential long-term maintenance and support needs.

My rule of them is the title of this post: buying appreciation. That’s a simple shortcut to remind myself of what I really want. I’m not just buying utility or adequacy. I’m buying long-term appreciation.

Share Button

Health24.com | Cats, dogs and snakebite: One pet has an advantage

One reason why cats have nine lives has emerged from an Australian study.

Cats are twice as likely as dogs to survive the bite of a poisonous snake, according to an international team of researchers. The reason: Cats’ blood clots faster than that of dogs.

For the study, the researchers compared the effects of 11 different snake venoms from around the world on the blood-clotting agents in dogs and cats.

“Snakebite is a common occurrence for pet cats and dogs across the globe and can be fatal,” said co-author Bryan Fry, an associate professor of biological sciences at the University of Queensland in Brisbane, Australia. “This is primarily due to a condition called venom-induced consumptive coagulopathy – where an animal loses its ability to clot blood and sadly bleeds to death.”

Behavioural differences

Australian eastern brown snakes are responsible for about 76% of pet snakebites in Australia each year.

“And while only 31% survive without anti-venom, cats are twice as likely to survive – at 66%,” Fry said in a university news release.

Cats are significantly more likely to survive if they are treated with anti-venom, and researchers said the reason was unclear until now. Dogs probably experience the failure of the blood to clot sooner than cats.

Behavioural differences between cats and dogs also are likely to increase dogs’ odds of death from snakebite.

“Dogs typically investigate with their nose and mouth, which are highly vascularized areas, whereas cats often swat with their paws,” Fry said. “And dogs are usually more active than cats, which is not great after a bite has taken place because the best practice is to remain as still as possible to slow the spread of venom through the body.”

Fast and fatal

Researchers hope their findings will lead to awareness of the short time available to get treatment for snakebitten dogs.

“I’ve had two friends lose big dogs to snakebites, dying in less than 10 minutes even though the eastern brown snakes responsible were not particularly large specimens,” Fry said. “This underscores how devastatingly fast and fatal snake venom can be to dogs.”

The report was published on 18 May in the journal Comparative Biochemistry and Physiology.

Image credit: Unsplash

NEXT ON HEALTH24X

Share Button

Health24.com | Could certain chemicals trigger coeliac disease?

  • Coeliac disease is an immune disorder where people can’t tolerate foods containing gluten
  • Researchers say that toxic chemicals in a range of products are associated with increased risk of the disorder
  • Gender appears to be an important factor in the link between the chemicals and the disorder

Toxic chemicals in a wide range of products are associated with an increased risk of coeliac disease in children and young adults, researchers say.

People with celiac disease – an immune disorder – can’t tolerate foods that contain gluten, a protein found in wheat, rye and barley.

New York University researchers analysed the blood of 30 children and young adults newly diagnosed with coeliac disease and compared results with those from 60 other young people. The investigators found that elevated levels of toxic chemicals found in pesticides, nonstick cookware and fire retardants were linked to a higher risk of having coeliac disease.

“Our study establishes the first measurable tie-in between environmental exposure to toxic chemicals and coeliac disease,” said senior study investigator and paediatric gastroenterologist Dr Jeremiah Levine.

Gender an important factor

“These results also raise the question of whether there are potential links between these chemicals and other autoimmune bowel diseases, which all warrant close monitoring and further study,” Levine added in a university news release.

In the study, children and young adults with high blood levels of pesticide-related chemicals called dichlorodiphenyldichlorethylenes (DDEs) were twice as likely to be newly diagnosed with coeliac disease as those without such levels.

Gender was an important factor in the link between toxic chemicals and risk of coeliac disease.

Females – who account for the majority of coeliac patients – with higher-than-normal pesticide exposure were at least eight times more likely to have coeliac disease.

Females with elevated levels of nonstick chemicals called perfluoroalkyls (PFAs), which are found in products like Teflon, were five to nine times more likely to have coeliac disease.

Only an association

Males were twice as likely to have coeliac disease if they had elevated blood levels of fire-retardant chemicals called polybrominated diphenyl ethers (PBDEs), according to the study.

The findings were published online in May in the journal Environmental Research.

Further research is needed to determine if these toxic chemicals are a direct cause of coeliac disease since this study only showed an association, said study co-investigator and health epidemiologist Dr Leonardo Trasande.

He noted that all the chemicals are known to disrupt animal and human hormone levels, which are crucial in sexual development and immune system function.

Image credit: Getty Images

Share Button

Health24.com | Birth control pill could cut women’s risk for asthma

  • According to a study, contraceptives could protect women against asthma
  • Hormonal events in a female’s reproductive cycle cause asthma-related effects in susceptible women 
  • How hormonal contraceptives can alter that relationship is, however, unclear

Could birth control pills build a bulwark against asthma?

New research suggests that hormonal contraceptives, which alter the natural ebb and flow of female hormones, may do just that.

A study of more than half a million women in the United Kingdom found that those who used hormonal contraceptives – be it pills or patches or shots – had a significantly lower risk of developing asthma than women who did not.

Asthma-related ripple effects

Female hormones have a mysterious relationship with asthma. Asthma is more common in boys than in girls during childhood, but after puberty women are more at risk for developing asthma and more likely to experience severe symptoms.

Every hormonal event in a female’s reproductive cycle – puberty, menstruation, pregnancy and menopause – has been shown to cause asthma-related ripple effects in some women who already have asthma.

“We know that more than 40% of women who have asthma experience increased exacerbations during their menstrual cycle, which points to the role of sex hormones,” said study author Bright Nwaru, of the University of Gothenburg in Sweden.

Still, how hormones are related to asthma in women, and how hormonal contraceptives may alter that relationship, remains unclear.

According to Dr Bruce Levy, chief of pulmonary and critical care at Brigham and Women’s Hospital in Boston, “There’s been a good bit of research, but I would say no definitive mechanism has been identified. I think most general practitioners, as well as specialists, are aware of this phenomenon, but why this occurs is still to be determined.”

Hormones play a role

Prior research on the impact of hormonal birth control on asthma development has been inconsistent, and this study was one of the first large-scale investigations to look into this relationship.

Dr Paul Greenberger is an allergist at Northwestern Medicine in Chicago. He said, “There’s been a focus on this area over the years, but it’s not fully understood. So, that’s why this is an intriguing study.”

One theory is that hormones play a role in the inflammation that narrows airways in patients with asthma, Greenberger said.

While Levy noted that this study can’t prove that taking hormonal contraceptives prevents asthma, it does reveal a strong connection.

“This is an association – it’s not proven, and it has to be presented with some acknowledgement that it’s not proof,” Levy said.

Longer use more effective

Nwaru and an international team of researchers derived the data for this study from a large, British-based health database. They tracked more than 500 000 women, aged 16 to 45, from 2000 through 2016. Throughout the study, around 25 000 of the women developed asthma.

After adjusting the data for factors such as obesity and smoking, which could muddy the results, the investigators found that women who used any type of hormonal contraceptives were at a 30% lower risk of developing asthma than women who didn’t.

And the benefit was greater for women who used it for longer – women who took hormonal contraceptives for seven years were less at risk than those who used them for three to four years, or one to two years.

“This adds another layer of importance to the observation,” Levy said. “It’s another line of evidence to suggest that this is not just a random association that happened to be found by chance, but that this is something that appears to be related to the duration of time that the birth control pills are used.”

In the study, published online recently in the Journal of Allergy & Clinical Immunology, the authors noted that more research is needed to better understand the relationship between female hormones and asthma.

Hormone-based therapy

Nwaru’s team also added that this topic should be investigated through a clinical trial to see if the results of this study can be confirmed in a controlled setting.

“Our findings do not suggest any changes in current management guidelines of asthma, but indicate the need for more confirmatory studies [e.g. clinical trials] to provide confirmation of our findings,” Nwaru said.

While it is unlikely that doctors will be prescribing birth control pills to prevent asthma anytime soon, further research could potentially lead to a hormone-based therapy for the prevention of asthma, the study team suggested.

Image credit: iStock

Share Button

Banish back pain

Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.

Advertising & Sponsorship

Mayo Clinic Marketplace

Check out these best-sellers and special offers on books and newsletters from Mayo Clinic.

Share Button

Linda Nolan and Bill Turnbull urge public not to delay cancer checks

Singer Linda Nolan and presenter Bill Turnbull urge people not to put off seeking important checks.

Share Button

Breast cancer: One-dose radiotherapy ‘as effective as full course’

A University College London study followed more than 2,000 women for five years after the treatment.

Share Button

The most sensitive instrument in the search for life beyond Earth

The question of whether life exists beyond the Earth is one of humanity’s most fundamental questions. Future NASA missions, for example, aim to examine the ice moons of Jupiter and Saturn, which may potentially shelter life in the liquid oceans underneath the thick layer of ice, on the ground. Proving traces of life beyond the Earth is extremely challenging, however. Highly sensitive instruments which take measurements on the ground with the greatest possible degree of autonomy and with high precision — millions of kilometers from the Earth and thus without direct support from humankind — are required.

An international group of researchers under the leadership of Andreas Riedo and Niels Ligterink at the University of Bern have now developed ORIGIN, a mass spectrometer which can detect and identify the smallest amounts of such traces of life. They describe the instrument in a recently published article in the specialist journal Nature Scientific Reports. Niels Ligterink from the Center for Space and Habitability (CSH) is the lead author of the international study, and co-author Andreas Riedo from the Physics Institute at the University of Bern developed the instrument in the laboratories of the space research and planetary sciences divison of the Physics Institute. Various international space agencies, particularly NASA, have already expressed interest in testing ORIGIN for future missions.

New instrument required

Since the first Mars mission “Viking” in the 1970s, humanity has been searching for traces of life on Mars using highly specialized instruments which are installed on landing platforms and rovers. In its early years, Mars was Earth-like, had a dense atmosphere and even liquid water. However, as Niels Ligterink explains, Mars lost its protective atmosphere over the course of time: “As a result of this, the surface of Mars is subjected to high solar and cosmic radiation which makes life on the surface impossible.” NASA’s “Curiosity” rover is currently examining Mars in detail but with no concrete indications of traces of life to date.

Since the discovery by the Cassini and Galileo missions of the global oceans beneath kilometers of ice layers on Jupiter’s moon Europa and Saturn’s moon Enceladus, these two bodies have increasingly become the focus of the search for extraterrestrial life for researchers. According to current knowledge, the oceans have all of the properties which are not only needed for the occurrence of life, but also which provide environments in which life can exist in the long term. NASA therefore plans to land a mission on Jupiter’s moon Europa around 2030 and take measurements on the ground. The goal: Identification of life. Co-author Prof. Dr. Peter Wurz from the Physics Institute at the University of Bern says: “Concepts which were specially developed for Mars cannot be simply applied to other bodies in our solar systembecause they are very different. New instruments with higher sensitivity and simpler and more robust analysis systems must be designed and used.”

Unprecedented measurement sensitivity for proof of life in space

ORIGIN is one such new instrument which outperforms previous space instruments many terms over in terms of its measurement sensitivty. Various international space agencies have expressed great interest in the instrument for future missions. Andreas Riedo says: “NASA has invited us to particpaite and test our instrument in the Arctic. The Artic is the optimal test environment in the context of the EUROPA LANDER mission, which should start in 2025, which will allow us to demonstrate the performance of ORIGIN.”

Amino acids are key components of life as we know it on Earth. Contemporaneous proof of certain amino acids on extraterrestrial surfaces, such as those of Europa, allow conclusions to be drawn about possible life. The measurement principle developed by the Bern-based researchers is simple. Niels Ligterink explains: “Laser pulses are directed at the surface to be examined. In the process, small amounts of material are detached, the chemical composition of which is analyzed by ORIGIN in a second step.” Andreas Riedo adds: “The compelling aspect of our technology is that no complicated sample preparation techniques, which could potentially affect the result, are required. This was one of the biggest problems on Mars until now,” says Riedo. The amino acids which have been analyzed with ORIGIN to date have a specific chemical fingerprint which allows them to be directly identified. Niels Ligterink: “To be honest, we didn’t expect that our first measurements would already be able to identify amino acids.”

The discovery of traces of past or present life on bodies in our solar system beyond the Earth is of great importance for a better understanding of the existence of life in the universe and its genesis. Andreas Riedo says: “Our new measurement technology is a real improvement on the instruments currently used on space missions. If we are taken along on a future mission, we may be able to answer one of humanity’s most fundamental questions with ORIGIN: Is there life in space?.”

Story Source:

Materials provided by University of Bern. Note: Content may be edited for style and length.

Share Button

Team creates better tool to aid COVID-19 diagnosis

An LSU Health New Orleans radiologist and evolutionary anatomist have teamed up to show the same techniques used for research on reptile and bird lungs can be used to help confirm the diagnosis of COVID-19 in patients. Their paper published in BMJ Case Reports demonstrates that 3D models are a strikingly clearer method for visually evaluating the distribution of COVID-19-related infection in the respiratory system.

Emma R. Schachner, PhD, Associate Professor of Cell Biology & Anatomy, and Bradley Spieler, MD, Vice Chairman of Radiology Research and Associate Professor of Radiology, Internal Medicine, Urology, & Cell Biology and Anatomy at LSU Health New Orleans School of Medicine, created 3D digital models from CT scans of patients hospitalized with symptoms associated with severe acute respiratory syndrome coronavirus (SARS-CoV-2).

Three patients who were suspected of having COVID-19 underwent contrast enhanced thoracic CT when their symptoms worsened. Two had tested positive for SARS-CoV-2, but one was reverse transcription chain reaction (RT-PCR) negative. But because this patient had compelling clinical and imaging, the result was presumed to be a false negative.

“An array of RT-PCR sensitivities has been reported, ranging from 30-91%,” notes Dr. Spieler. “This may be the result of relatively lower viral loads in individuals who are asymptomatic or experience only mild symptoms when tested. Tests performed when symptoms were resolving have also resulted in false negatives, which seemed to be the result in this case.”

Given diagnostic challenges with respect to false negative results by RT-PCR, the gold standard for COVID-19 diagnostic screening, CT can be helpful in establishing this diagnosis. Importantly, these CT features can range in form and structure and appear to correlate with disease progression. This allows for 3D segmentation of the data in which lung tissue can be volumetrically quantified or airflow patterns could be modeled.

The CT scans were all segmented into 3D digital surface models using the scientific visualization program Avizo (Thermofisher Scientific) and techniques that the Schachner Lab uses for evolutionary anatomy research.

“The full effect of COVID-19 on the respiratory system remains unknown, but the 3D digital segmented models provide clinicians a new tool to evaluate the extent and distribution of the disease in one encapsulated view,” adds Spieler. “This is especially useful in the case where RT-PCR for SARS-CoV-2 is negative but there is strong clinical suspicion for COVID-19.”

To date, there haven’t been good models of what COVID is doing to the lungs. So, this project focused on the visualization of the lung damage in the 3D models as compared to previous methods that have been published — volume-rendered models and straight 2D screen shots of CT scans and radiographs.

“Previously published 3D models of lungs with COVID-19 have been created using automated volume rendering techniques,” says Dr. Schachner. “Our method is more challenging and time consuming, but results in a highly accurate and detailed anatomical model where the layers can be pulled apart, volumes quantified, and it can be 3D printed.”

The three models all show varying degrees of COVID-19 related infection in the respiratory tissues — particularly along the back of the lungs, and bottom sections. They more clearly show COVID-19-related infection in the respiratory system compared to radiographs (X-rays), CT scans, or RT-PCR testing alone.

Schachner and Spieler are now segmenting more models for a larger follow up project.

Share Button

Toward a coronavirus breathalyzer test

Few people who have undergone nasopharyngeal swabs for coronavirus testing would describe it as a pleasant experience. The procedure involves sticking a long swab up the nose to collect a sample from the back of the nose and throat, which is then analyzed for SARS-CoV-2 RNA by the reverse-transcription polymerase chain reaction (RT-PCR). Now, researchers reporting in ACS Nano have developed a prototype device that non-invasively detected COVID-19 in the exhaled breath of infected patients.

In addition to being uncomfortable, the current gold standard for COVID-19 testing requires RT-PCR, a time-consuming laboratory procedure. Because of backlogs, obtaining a result can take several days. To reduce transmission and mortality rates, healthcare systems need quick, inexpensive and easy-to-use tests. Hossam Haick, Hu Liu, Yueyin Pan and colleagues wanted to develop a nanomaterial-based sensor that could detect COVID-19 in exhaled breath, similar to a breathalyzer test for alcohol intoxication. Previous studies have shown that viruses and the cells they infect emit volatile organic compounds (VOCs) that can be exhaled in the breath.

The researchers made an array of gold nanoparticles linked to molecules that are sensitive to various VOCs. When VOCs interact with the molecules on a nanoparticle, the electrical resistance changes. The researchers trained the sensor to detect COVID-19 by using machine learning to compare the pattern of electrical resistance signals obtained from the breath of 49 confirmed COVID-19 patients with those from 58 healthy controls and 33 non-COVID lung infection patients in Wuhan, China. Each study participant blew into the device for 2-3 seconds from a distance of 1¬-2 cm. Once machine learning identified a potential COVID-19 signature, the team tested the accuracy of the device on a subset of participants. In the test set, the device showed 76% accuracy in distinguishing COVID-19 cases from controls and 95% accuracy in discriminating COVID-19 cases from lung infections. The sensor could also distinguish, with 88% accuracy, between sick and recovered COVID-19 patients. Although the test needs to be validated in more patients, it could be useful for screening large populations to determine which individuals need further testing, the researchers say.

The authors acknowledge funding from the Technion-Israel Institute of Technology.

Story Source:

Materials provided by American Chemical Society. Note: Content may be edited for style and length.

Share Button